bms-986251 Report issue

Small molecule Experimental

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: C[C@H]1C[C@H](C(=O)O)CC[C@H]1C(=O)N1CC[C@@]2(S(=O)(=O)c3ccc(F)cc3)c3ccc(C(F)(C(F)(F)F)C(F)(F)F)cc3CC[C@@H]12
  • InChIKey: JQORWGARJVSRBA-QOTTZFGFSA-N
  • Mol. Mass: 667.62
  • ALogP: 6.47
  • ChEMBL Molecule:
    bms-986251  
More Chemistry

Pharmacology

Indications (5)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (5)


 

Arthritis, Rheumatoid (Phase 1/Phase 2)

Inflammatory Bowel Diseases (Phase 1/Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 1/Phase 2)

Psoriasis (Phase 1/Phase 2)

Spondylitis, Ankylosing (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial Organizations: 0

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue